| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
|
Lancet
|
2010
|
6.02
|
|
2
|
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.
|
AIDS
|
2009
|
5.72
|
|
3
|
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
|
J Infect Dis
|
2011
|
3.16
|
|
4
|
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.
|
J Acquir Immune Defic Syndr
|
2014
|
2.79
|
|
5
|
Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.
|
AIDS
|
2011
|
2.38
|
|
6
|
Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi.
|
Trop Med Int Health
|
2010
|
2.28
|
|
7
|
Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
|
Trop Med Int Health
|
2009
|
2.21
|
|
8
|
Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
|
Trop Med Int Health
|
2014
|
1.76
|
|
9
|
Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.
|
BMC Infect Dis
|
2011
|
1.47
|
|
10
|
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
|
PLoS One
|
2013
|
1.43
|
|
11
|
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring.
|
AIDS
|
2012
|
1.32
|
|
12
|
Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
|
PLoS One
|
2013
|
1.32
|
|
13
|
Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre- post comparison.
|
BMC Pediatr
|
2009
|
1.28
|
|
14
|
Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi).
|
J Acquir Immune Defic Syndr
|
2014
|
1.26
|
|
15
|
Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights.
|
BMC Pediatr
|
2009
|
1.17
|
|
16
|
Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi.
|
Clin Infect Dis
|
2012
|
1.17
|
|
17
|
Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
|
Trop Med Int Health
|
2010
|
1.13
|
|
18
|
Negotiating multiple barriers: health workers' access to counselling, testing and treatment in Malawi.
|
AIDS Care
|
2010
|
1.13
|
|
19
|
Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study.
|
AIDS Behav
|
2013
|
1.10
|
|
20
|
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
|
Clin Infect Dis
|
2012
|
1.10
|
|
21
|
National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links.
|
Health Res Policy Syst
|
2011
|
1.04
|
|
22
|
Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
|
Trop Med Int Health
|
2012
|
1.04
|
|
23
|
Re-treatment tuberculosis cases categorised as "other": are they properly managed?
|
PLoS One
|
2011
|
0.94
|
|
24
|
Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.
|
BMC Public Health
|
2014
|
0.94
|
|
25
|
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
|
Epidemiology
|
2016
|
0.92
|
|
26
|
Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.
|
J Acquir Immune Defic Syndr
|
2014
|
0.92
|
|
27
|
Simplifying ART cohort monitoring: can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
|
BMC Health Serv Res
|
2012
|
0.92
|
|
28
|
Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.
|
PLoS One
|
2012
|
0.90
|
|
29
|
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
|
PLoS Med
|
2013
|
0.89
|
|
30
|
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs.
|
Pediatr Infect Dis J
|
2014
|
0.88
|
|
31
|
Defining and analyzing retention-in-care among pregnant and breastfeeding HIV-infected women: unpacking the data to interpret and improve PMTCT outcomes.
|
J Acquir Immune Defic Syndr
|
2014
|
0.85
|
|
32
|
Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy.
|
Bull World Health Organ
|
2011
|
0.84
|
|
33
|
Managing HIV and tuberculosis in sub-Saharan Africa.
|
Lancet
|
2006
|
0.84
|
|
34
|
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.
|
J Acquir Immune Defic Syndr
|
2015
|
0.82
|
|
35
|
Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate.
|
Contraception
|
2013
|
0.82
|
|
36
|
Health leadership in sub-Saharan Africa.
|
Trop Doct
|
2009
|
0.81
|
|
37
|
The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
|
J Acquir Immune Defic Syndr
|
2017
|
0.81
|
|
38
|
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi.
|
J Acquir Immune Defic Syndr
|
2016
|
0.79
|
|
39
|
Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.
|
PLoS One
|
2011
|
0.79
|
|
40
|
Managing HIV-infected children in a low-resource, public clinic: a comparison of nurse vs. clinical officer practices in ART refill, calculation of adherence and subsequent appointments.
|
J Int AIDS Soc
|
2012
|
0.79
|
|
41
|
Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
|
AIDS
|
2016
|
0.78
|
|
42
|
Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
|
J Acquir Immune Defic Syndr
|
2015
|
0.77
|
|
43
|
Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi.
|
J Acquir Immune Defic Syndr
|
2016
|
0.77
|
|
44
|
Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
45
|
Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
46
|
HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi.
|
Emerg Infect Dis
|
2016
|
0.75
|
|
47
|
Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, Malawi.
|
Trop Med Int Health
|
2011
|
0.75
|
|
48
|
Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.
|
AIDS
|
2017
|
0.75
|
|
49
|
Evaluating the systems used to monitor HIV populations accessing therapy and care in low-income and lower-middle-income countries.
|
AIDS
|
2012
|
0.75
|